Cognition and the course of prodromal Parkinson's disease

Abstract

Prospective data on cognition in prodromal Parkinson's disease are limited. The objectives of this study were to assess in prodromal PD (1) if baseline cognition predicts conversion to clinical PD, (2) if baseline dopamine transporter binding predicts longitudinal changes in cognition, and (3) if impaired olfaction predicts future cognitive decline.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Oct 24, 2017
• Source ID: 10.1002/mds.27189

Entities

People

• Andrew Siderowf
• Daniel Weintraub
• Danna Jennings
• David Oakes
• John Seibyl
• Keith A. Hawkins
• Kenneth Marek
• Lana M. Chahine
• Matthew B. Stern
• Shirley Eberly
• The Pars Investigators

Organizations

• Eli Lilly and Company
• Institute for Neurodegenerative Disorders
• United States Department of Defense
• University of Pennsylvania
• University of Rochester
• Veterans Health Administration
• Yale University

Tags

Fields of Study

• Medicine
• Psychology

Readers

• Neurodegenerative Parkinson's Disease and Rickettsial Disease handbook, including the data level of dopamine, BC, neurons, and PD.
• Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.
• Wave Propagation and Nonlinear Chaotic Dynamics.